Clik here to view.
Stryker’s Q4 beats The Street
Stryker (NYSE:SYK) beat the consensus forecast on Wall Street with its 4th-quarter and full-year results, sales and earnings, sending share prices up today in late trading. The Kalamazoo, Mich.-based...
View ArticleClik here to view.
In brief: Brazil’s ANVISA recognizes second MDSAP auditor
By Stewart Eisenhart, Emergo Group Brazilian medical device market regulator ANVISA has named a second firm, TÜV SÜD America, as an accredit audit organization under the international Medical Device...
View ArticleClik here to view.
Judge boots Boston Scientific counterfeit mesh case to the FDA
A federal judge yesterday booted a purported class-action racketeering lawsuit filed against Boston Scientific (NYSE:BSX), accusing the medical device maker of illegally smuggling counterfeit resin...
View ArticleClik here to view.
Bidding war heats up for Toshiba Medical
A bidding war for Toshiba (TYO:6502) subsidiary Toshiba Medical is reportedly heating up among a slew of private equity players and rival corporations. Toshiba, which said last month that it’s seeking...
View ArticleClik here to view.
St. Jude Medical’s Q4 profits cut in half
Fourth-quarter profits for St. Jude Medical (NYSE:STJ) were off more than 50%, the medical device company said today, as its $3 billion acquisition of Thoratec put a $179 million hit on the bottom...
View ArticleClik here to view.
Stryker CFO Jellison retires, Boehnlein steps up | Personnel Moves
Stryker (NYSE:SYK) said yesterday that CFO and veep William Jellison is retiring, and will be replaced by former medsurg & neurotechnology group CFO Glenn Boehnlein. The Kalamazoo, Mich.-based...
View ArticleClik here to view.
Nuo Therapeutics files for bankruptcy
Wound care company Nuo Therapeutics (OTC:NUOT) said yesterday that it’s declaring Chapter 11 bankruptcy a little more than 2 years after raising $35 million. Formerly known as Cytomedix, Nuo...
View ArticleClik here to view.
Novartis taps Hospira-sale engineer exec Ball to revive slumping Alcon
Novartis (NYSE:NVS) is looking to revitalize its slumping Alcon eye care division by picking up medical vet Michael Ball, who recently organized Hospira’s $15 billion sale to Pfizer (NYSE:PFE). Ball...
View ArticleClik here to view.
TransEnterix surges on takeover speculation
TransEnterix (NYSE:TRXC) shares surged today on speculation that the robot-assisted surgery company could be acquired by Johnson & Johnson (NYSE:JNJ). Johnson & Johnson chairman & CEO said...
View ArticleClik here to view.
Admedus inks exclusive distro deal with Coroneo
Admedus (ASX:AHZ) said today it inked an exclusive distribution agreement with Coroneo to sell its Extra aortic annuloplasty ring ing and other heart valve surgery instruments in Germany and the U.K....
View ArticleClik here to view.
Velano Vascular wins FDA nod for new blood draw device
Velano Vascular said today that it won 510(k) clearance from the FDA for a new iteration of its needle-free blood draw device. San Francisco-based Velano, which raised a $5 million Series A round in...
View ArticleClik here to view.
MEPS Real-Time expands staff, headquarters
RFID inventory management company MEPS Real-Time said it is adding to its sales, marketing, product management and engineering team, as well as expanding its Carlsbad, Calif.-based headquarters nearly...
View ArticleClik here to view.
Greatbatch wins $37.5m patent infringement suit with AVX
Greatbatch (NYSE:GB) said yesterday it won $37.5 million in damages after a jury in the U.S. District Court for the District of Delaware ruled in its favor during a patent infringement case between...
View ArticleClik here to view.
Minnetronix raises $20m
Minnetronix said yesterday it raised $20 million in equity capital through a minority investment from Altaris Capital Partners. The investment marks the 1st time Minnetronix has raised outside equity...
View ArticleClik here to view.
Natus Medical shares jump on Q4, FY2015 EPS beat
Natus Medical (NSDQ:BABY) saw shares jump slightly after reporting Q4 and FY2015 earnings that beat the Street, with revenue numbers just squeaking under expectations. Pleasanton, Calif.-based Natus...
View ArticleClik here to view.
Edwards invests in Fogarty Institute
The Fogarty Institute for Innovation said today it received a grant from Edwards Lifesciences (NYSE:EW) to support its medical technology innovation and Lefteroff Internship programs. The programs...
View ArticleClik here to view.
MassDevice.com +3 | The top 3 medtech stories for January 27, 2016
Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the...
View ArticleClik here to view.
Johnson & Johnson to pay $120m in 1st mesh settlement
Johnson & Johnson (NYSE:JNJ) is making the 1st move in settling thousands of lawsuits from women who claim the company’s vaginal-mesh inserts caused organ damage and serious pain, paying $120...
View ArticleClik here to view.
2016: The year of diversity in clinical trials
By: Robert M. Califf, M.D. Controlled clinical trials provide a critical base of evidence for evaluating whether a medical product is effective before the product is approved for marketing. One...
View ArticleClik here to view.
HeartWare spikes Valtech Cardio deal, settles proxy war
HeartWare International (NSDQ:HTWR) today backed out of its acquisition of Israeli replacement heart valve maker Valtech Cardio and settled a proxy war with activist investor Engaged Capital....
View Article
